Eurofins 9M Revenues €5.61 Bln

By Reuters News

- Eurofins Scientific SE EUFI.PA:

  • EUROFINS DELIVERS IMPROVING ORGANIC GROWTH THROUGH 9M 2026; REMAINS ON TRACK FOR 2026 AND MID-TERM PROFITABILITY OBJECTIVES

  • REPORTED REVENUES IN 9M 2026 TOTAL €5,614M, UP 3.7% VERSUS 9M 2025

  • EXPECTS 2026 REVENUES FROM ACQUISITIONS ABOVE PREVIOUS OBJECTIVE OF €250M

  • EXPECTS ADJUSTED EBITDA MARGIN IMPROVEMENT IN 2026 ABOVE FY 2025 MARGIN OF 22.5%

  • FY 2026 ORGANIC GROWTH IS LIKELY TO BE BELOW PREVIOUS MID-SINGLE-DIGIT OBJECTIVE

Further company coverage: EUFI.PA

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.